The Valley Desk

NCT07037433 · Interventional trial

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Overall registry status Active not recruiting

Phase 3

Conditions Atherosclerotic Cardiovascular Disease, Obesity, Overweight

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov